Home
>
National Drug Code (NDC)
>
Baclofen
Baclofen - 0832-1025-50 - (Baclofen)
Drug Information of Baclofen
| Product NDC: | 0832-1025 |
| Proprietary Name: | Baclofen |
| Non Proprietary Name: | Baclofen |
| Active Ingredient(s): | 20 mg/1 & nbsp; Baclofen |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Baclofen
| Product NDC: | 0832-1025 |
| Labeler Name: | Upsher-Smith Laboratories, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA074584 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20101020 |
Package Information of Baclofen
| Package NDC: | 0832-1025-50 |
| Package Description: | 500 TABLET in 1 BOTTLE (0832-1025-50) |
NDC Information of Baclofen
| NDC Code | 0832-1025-50 |
| Proprietary Name | Baclofen |
| Package Description | 500 TABLET in 1 BOTTLE (0832-1025-50) |
| Product NDC | 0832-1025 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Baclofen |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 20101020 |
| Marketing Category Name | ANDA |
| Labeler Name | Upsher-Smith Laboratories, Inc. |
| Substance Name | BACLOFEN |
| Strength Number | 20 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | GABA A Agonists [MoA],GABA B Agonists [MoA],gamma-Aminobutyric Acid-ergic Agonist [EPC] |
